Tiotropium respimat(®) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T(H)2 inflammatory status

por Yang, WH, Casale, T, Bateman, ED, Dahl, R, Pizzichini, E, Vandewalker, M, Virchow, JC, Engel, M, Moroni-Zentgraf, PM, Schmidt, H, Kerstjens, HAM
Publicado 2014